HER2-RELATED BIOMARKERS PREDICT CLINICAL OUTCOMES WITH TRASTUZUMAB DERUXTECAN TREATMENT IN PATIENTS WITH HER2-EXPRESSING METASTATIC COLORECTAL CANCER: BIOMARKER ANALYSES OF DESTINY-CRC01

Abstract DESTINY-CRC01 secchia stadium photos (NCT03384940) was a multicentre, open-label, phase 2 study that investigated the safety and efficacy of trastuzumab deruxtecan (T-DXd) in patients with human epidermal growth factor receptor 2 (HER2)-expressing metastatic colorectal cancer (CRC).The present exploratory biomarker analysis aims to investi

Abstract We propose a theoretical concept of a far-field radiative thermal rectification device that uses a phase change material to achieve a high degree of asymmetry in radiative heat transfer.The proposed device has a multilayer structure on one side and a blackbody on other side.The multilayer structure consists of transparent thin film hard st

Hairy cell leukemia (HCL), an uncommon cancer affecting B-lymphocytes primarily pituitary gland in spanish in the bone marrow and spleen, is identified by abnormal projections on malignant B cells, which give the illness its name.This condition is less frequently observed in Asian populations compared with individuals from American and European bac